Re: Jean F.P. Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.040: Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer

Alberto Briganti; Giorgio Gandaglia; Markus Graefen; Steven Joniau; R. Jeffrey Karnes; Francesco Montorsi

doi:10.1016/j.eururo.2021.02.024

Re: Jean F.P. Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.040: Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer

Alberto Briganti, Giorgio Gandaglia, Markus Graefen, Steven Joniau, R. Jeffrey Karnes, Francesco Montorsi

Urology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	e154-e156
Journal	European urology
Volume	79
Issue number	5
DOIs	https://doi.org/10.1016/j.eururo.2021.02.024
State	Published - May 2021

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.eururo.2021.02.024

Cite this

Briganti, A., Gandaglia, G., Graefen, M., Joniau, S., Karnes, R. J., & Montorsi, F. (2021). Re: Jean F.P. Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.040: Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer. European urology, 79(5), e154-e156. https://doi.org/10.1016/j.eururo.2021.02.024

Re: Jean F.P. Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.040: Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer. / Briganti, Alberto; Gandaglia, Giorgio; Graefen, Markus et al.
In: European urology, Vol. 79, No. 5, 05.2021, p. e154-e156.

Research output: Contribution to journal › Letter › peer-review

Briganti, A, Gandaglia, G, Graefen, M, Joniau, S, Karnes, RJ & Montorsi, F 2021, 'Re: Jean F.P. Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.040: Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer', European urology, vol. 79, no. 5, pp. e154-e156. https://doi.org/10.1016/j.eururo.2021.02.024

Briganti A, Gandaglia G, Graefen M, Joniau S, Karnes RJ, Montorsi F. Re: Jean F.P. Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.040: Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer. European urology. 2021 May;79(5):e154-e156. doi: 10.1016/j.eururo.2021.02.024

Briganti, Alberto ; Gandaglia, Giorgio ; Graefen, Markus et al. / Re : Jean F.P. Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.040: Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer. In: European urology. 2021 ; Vol. 79, No. 5. pp. e154-e156.

@article{3cbc7075707b4da492e07b63c2a69c7d,

title = "Re: Jean F.P. Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.040: Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer",

author = "Alberto Briganti and Giorgio Gandaglia and Markus Graefen and Steven Joniau and Karnes, {R. Jeffrey} and Francesco Montorsi",

year = "2021",

month = may,

doi = "10.1016/j.eururo.2021.02.024",

language = "English (US)",

volume = "79",

pages = "e154--e156",

journal = "European urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - Re

T2 - Jean F.P. Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.040: Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer

AU - Briganti, Alberto

AU - Gandaglia, Giorgio

AU - Graefen, Markus

AU - Joniau, Steven

AU - Karnes, R. Jeffrey

AU - Montorsi, Francesco

PY - 2021/5

Y1 - 2021/5

UR - http://www.scopus.com/inward/record.url?scp=85103773236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85103773236&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2021.02.024

DO - 10.1016/j.eururo.2021.02.024

M3 - Letter

C2 - 33637367

AN - SCOPUS:85103773236

SN - 0302-2838

VL - 79

SP - e154-e156

JO - European urology

JF - European urology

IS - 5

ER -

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this